Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies

PURPOSE: Bronchodilator reversibility has been reported in patients with COPD, although correlations between reversibility and treatment response are unclear. The effect of reversibility on lung function, health status, and dyspnea was assessed in patients with moderate-to-severe COPD receiving glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohar, Jill A, Bowling, Alyssa, Goodin, Thomas, Price, Barry, Ozol-Godfrey, Ayca, Sharma, Sanjay, Sanjar, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388797/
https://www.ncbi.nlm.nih.gov/pubmed/30863047
http://dx.doi.org/10.2147/COPD.S194102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388797/
https://www.ncbi.nlm.nih.gov/pubmed/30863047
http://dx.doi.org/10.2147/COPD.S194102

Ejemplares similares